Latest Breaking News On - Biopharma communications - Page 1 : comparemela.com

Dendritic Cell Vaccine Safely Boosts Immunity in Myeloma Patients

Dendritic Cell Vaccine Safely Boosts Immunity in Myeloma Patients
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesFrederickl lockeUmoja biopharmaGerson lehrman groupAmerican society of hematologyLymphoma society clinical scholar awardClinical cancer researchTherapy solutionsBiopharma communicationsSociety for immunotherapy of cancerAptitude healthCellular immunotherapy department at moffitt cancer centerNational cancer instituteAmerican association for cancer researchBristol myers squibbBottom line

A dendritic cell vaccine was safe and induced

A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe and immunogenic and was associated with durable clinical responses in patients with high-risk multiple myeloma.

United statesUmoja biopharmaFrederickl lockeLymphoma society clinical scholar awardAptitude healthCellular immunotherapy department at moffitt cancer centerGerson lehrman groupBristol myers squibbBiopharma communicationsTherapy solutionsAmerican association for cancer researchNational cancer instituteAmerican society of hematologyClinical cancer researchSociety for immunotherapy of cancerBottom line

Avantor® to Collaborate with GeminiBio to Bring Custom Hydrated Solutions and Cell Culture Media to Biopharma Customers

/PRNewswire/ Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced.

Hannah mooney mackPetro kacurBrian parkerBiopharma communicationsPrnewswire avantor incGer brophyExecutive vice presidentBiopharma productionAvantor and financial newsComputer amp electronicsMedical equipmentMining amp metalsHealth care amp hospitalsMedical pharmaceuticalsGeneral manufacturing

Avantor® and Cytovance Biologics Collaborate to Accelerate Plasmid DNA Development for Biopharma Customers

/PRNewswire/ Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced.

Hannah mooney mackNaomi seresinheCytovance biologicsPetro kacurCytovance biologics incBiopharma communicationsAvantor incCytovance biologicGer brophyExecutive vice presidentBiopharma productionSenior vice presidentBusiness operationsMedia contactMooney mackExternal communications

Avantor® Opens Single-Use Logistics Hub to Strengthen Global Biopharma Supply Chain

/PRNewswire/ Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced.

United statesNew jerseyNorth carolinaHannah mooney mackBiopharma communicationsCompany devensPrnewswire avantor incGer brophyExecutive vice presidentBiopharma productionNorth americaAvantor and financial news